Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Medecine Et Maladies Infectieuses|January 8, 2017
Influenza B burden during seasonal influenza epidemics in FranceA Mosnier, I Daviaud, J S Casalegno, et al.The Journal of Infectious Diseases|September 9, 1999
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trialB Hoen, B Dumon, M Harzic, et al.Virus Genes|January 10, 2002
High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French GuianaD Moynet, J F Pouliquen, D Londos-Gagliardi, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohortB Masquelier, M L Chaix, M Burgard, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
Predominance of CCR5-dependent HIV-1 subtype E isolates in CambodiaE Menu, J M Reynes, M C Müller-Trutwin, et al.Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.Journal of Medical Virology|May 7, 2002
Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infectionP Trimoulet, D Neau, B Le Bail, et al.European Journal of Clinical Investigation|April 16, 1998
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodiesJ Constans, V Guérin, A Couchouron, et al.Journal of Virology|October 21, 2011
Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cellsO Cosnefroy, A Tocco, P Lesbats, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitroR Salpini, M Surdo, M F Cortese, et al.Pageof 7